Status: current, Defined. Date: 31-Mar 2013. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3012371000168113 | Ondansetron (Kabi) (ondansetron 4 mg / 2 mL) injection, 1 x 2 mL ampoule (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3012381000168111 | Ondansetron (Kabi) 4 mg/2 mL injection, 2 mL ampoule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ondansetron (Kabi) 4 mg/2 mL injection, 2 mL ampoule | Is a | trade product pack | true | Inferred relationship | Some | ||
| Ondansetron (Kabi) 4 mg/2 mL injection, 2 mL ampoule | Is a | ondansetron 4 mg/2 mL injection, 2 mL ampoule | true | Inferred relationship | Some | ||
| Ondansetron (Kabi) 4 mg/2 mL injection, 2 mL ampoule | has TPUU | Ondansetron (Kabi) 4 mg/2 mL injection, 2 mL ampoule | true | Inferred relationship | Some | 1 | |
| Ondansetron (Kabi) 4 mg/2 mL injection, 2 mL ampoule | has TP | Ondansetron (Kabi) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ondansetron (Kabi) 4 mg/2 mL injection, 2 mL ampoule | Is a | True | Ondansetron (Kabi) 4 mg/2 mL injection, 2 mL ampoule | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR